Randomized Trial of Standard Adjuvant Chemotherapy Regimens Versus Capecitabine in Older Women With Early Breast Cancer: 10-Year Update of the CALGB 49907 Trial - Concepedia

Concepedia

Publication | Open Access

Randomized Trial of Standard Adjuvant Chemotherapy Regimens Versus Capecitabine in Older Women With Early Breast Cancer: 10-Year Update of the CALGB 49907 Trial

DOI Full Paper Access

71

Citations

38

References

2019

Year

Hyman B. Muss, Mei‐Yin C. Polley, Donald A. Berry, Heshan Liu, Constance Cirrincione, Maria Theodoulou, Ann M. Mauer, Alice B. Kornblith, Ann H. Partridge, Lynn G. Dressler,

Journal of Clinical Oncology

Abstract

With longer follow-up, RFS remains superior for standard adjuvant chemotherapy versus capecitabine, especially in patients with hormone receptor-negative disease. Competing risks in this older population dilute overall survival benefits.

References

	Year	Citations

Page 1